GH Research logo

GH ResearchNASDAQ: GHRS

Profile

Sector:

Healthcare

Industry:

Biotechnology

Country:

Ireland

IPO:

25 June 2021

Next earnings report:

23 August 2024

Last dividends:

N/A

Next dividends:

N/A
$626.94 M
-56%vs. 3y high
70%vs. sector
-vs. 3y high
-vs. sector
-41%vs. 3y high
71%vs. sector
-vs. 3y high
-vs. sector

Price

regular market | Wed, 03 Jul 2024 13:30:00 GMT
$12.05+$0.14(+1.18%)

Dividend

No data over the past 3 years
No data over the past 3 years

Analysts recommendations

Institutional Ownership

GHRS Latest News

Recent Price Trend in GH Research (GHRS) is Your Friend, Here's Why
Zacks Investment Research13 May 2024 Sentiment: POSITIVE

GH Research (GHRS) is a strong stock that has caught the attention of investors seeking to capitalize on stocks showing recent price strength.

How Much Upside is Left in GH Research PLC (GHRS)? Wall Street Analysts Think 321.28%
Zacks Investment Research05 March 2024 Sentiment: POSITIVE

The average of price targets set by Wall Street analysts indicates a potential upside of 321.3% in GH Research PLC (GHRS). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

What type of business is GH Research?

GH Research PLC, a clinical-stage biopharmaceutical company, engages in developing various therapies for the treatment of psychiatric and neurological disorders. The company focuses on developing 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) therapies for the treatment of patients with treatment-resistant depression (TRD). Its lead program is GH001, an inhalable 5-MeO-DMT product candidate that has completed two Phase 1 clinical trials and Phase 1/2 clinical trial in patients with TRD. The company also develops GH002, an injectable 5-MeO-DMT product candidate; and GH003, an intranasal 5-MeO-DMT product candidate, which are in preclinical development trials with a focus on psychiatric and neurological disorders. GH Research PLC was incorporated in 2018 and is based in Dublin, Ireland.

What sector is GH Research in?

GH Research is in the Healthcare sector

What industry is GH Research in?

GH Research is in the Biotechnology industry

What country is GH Research from?

GH Research is headquartered in Ireland

When did GH Research go public?

GH Research initial public offering (IPO) was on 25 June 2021

What is GH Research website?

https://www.ghres.com

Is GH Research in the S&P 500?

No, GH Research is not included in the S&P 500 index

Is GH Research in the NASDAQ 100?

No, GH Research is not included in the NASDAQ 100 index

Is GH Research in the Dow Jones?

No, GH Research is not included in the Dow Jones index

When does GH Research report earnings?

The next expected earnings date for GH Research is 23 August 2024